Neshima Medical

Neshima Medical is a preclinical stage therapeutic company, with a mission to reduce mortality rates and hospitalization days. Neshima’s innovation is utilizing its patented liquid-foam therapy (LiFT™) for respiratory drug delivery. The vision of the company is to treat severe pneumonia and asthma using existing small molecules, COPD using topical cell therapy, IPF using slow-release particles, CF using gene therapy, and more. LiFT™ enables for the first-time topical and fast administration of high doses of therapeutics throughout the lungs, and through constricted and mucus obstructed airways, including cells and large size particles (×10 compared to nebulizers, over 50 μm).